133 related articles for article (PubMed ID: 126168)
1. Reversible inhibition of (Na+ + K+)-ATPase with a cardiac glycoside.
Ross CR; Pessah NI
Eur J Pharmacol; 1975 Aug; 33(1):223-6. PubMed ID: 126168
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationships of cardiotonic steroids for the inhibition of sodium- and potassium-dependent adenosine triphosphatase. 3. Dissociation rate constants of various enzyme-cardiac glycoside complexes formed in the presence of sodium, magnesium, and adenosine triphosphate.
Yoda A; Yoda S
Mol Pharmacol; 1974 May; 10(3):494-500. PubMed ID: 4277671
[No Abstract] [Full Text] [Related]
3. Structure-activity relationships of cardiotonic steroids for the inhibition of sodium- and potassium-dependent adenosine triphosphatase. II. Association rate constants of various enzyme-cardiac glycoside complexes.
Yoda A; Yoda S; Sarrif AM
Mol Pharmacol; 1973 Nov; 9(6):766-73. PubMed ID: 4271632
[No Abstract] [Full Text] [Related]
4. Structue-activity relationships of cardiotonic steroids for the inhibition of sodium- and potassium-dependent adenosine triphosphatase. I. Dissociation rate constants of various enzyme-cardiac glycoside complexes formed in the presence of magnesium and phosphate.
Yoda A
Mol Pharmacol; 1973 Jan; 9(1):51-60. PubMed ID: 4265446
[No Abstract] [Full Text] [Related]
5. Na, K-activated ATPase activity during and after arrhythmic response to AY-22-241 in the canine heart.
Dutta S; Zavecz JH; Marks BH; Rhee HM; Brar S; Richards SR; Bhat HB
Ann N Y Acad Sci; 1974; 242(0):671-82. PubMed ID: 4279614
[No Abstract] [Full Text] [Related]
6. Variability in ouabain-induced inhibition of human erythrocyte membrane (Na+ K+)-ATPase.
Schrier SL; Giberman E; Katchalski E
Biochim Biophys Acta; 1969 Jul; 183(2):397-400. PubMed ID: 4239999
[No Abstract] [Full Text] [Related]
7. Recent advances in cardiac glycoside-Na+,K+-ATPase interaction.
Wallick ET; Lindenmayer GE; Lane LK; Allen JC; Pitts BJ; Schwartz A
Fed Proc; 1977 Aug; 36(9):2214-8. PubMed ID: 142025
[TBL] [Abstract][Full Text] [Related]
8. Cardiac glycoside sensitivity of (Na + +K + )-activated ATPase in new-born rats.
Akera T; Hook JB; Tobin T; Brody TM
Res Commun Chem Pathol Pharmacol; 1972 Nov; 4(3):699-706. PubMed ID: 4264311
[No Abstract] [Full Text] [Related]
9. On the reversibility of binding of cardiotonic steroids to a partially purified (Na+K)-activated adenosinetriphosphatase from beef brain.
Yoda A; Hokin LE
Biochem Biophys Res Commun; 1970 Aug; 40(4):880-6. PubMed ID: 4251204
[No Abstract] [Full Text] [Related]
10. [New aspects on the mode of action of cardiac glycosides].
Fricke U
Fortschr Med; 1976 Nov; 94(32):1037-45. PubMed ID: 136410
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of cardiac glycoside inhibition of the (Na+-K+)-dependent ATPase from cardiac tissue.
Matsui H; Schwartz A
Biochim Biophys Acta; 1968 Mar; 151(3):655-63. PubMed ID: 4230809
[No Abstract] [Full Text] [Related]
12. Cross-resistance and biochemical studies with two classes of HeLa cell mutants resistant to cardiac glycosides. The unusual behavior of cardenolide SC4453.
Gupta RS; Chopra A
J Biol Chem; 1985 Jun; 260(11):6843-50. PubMed ID: 2987235
[TBL] [Abstract][Full Text] [Related]
13. Reversibility of the interaction of strophanthidin bromoacetate with the cardiotonic steroid binding site of sodium- and potassium-dependent adenosine triphosphatase.
Tobin T; Akera T; Ku D; Lu MC
Mol Pharmacol; 1973 Sep; 9(5):676-85. PubMed ID: 4274674
[No Abstract] [Full Text] [Related]
14. The difference in sensitivity to cardiac steroids of (Na++K+)-stimulated ATPase and amino acid transport in the intestinal mucosa of the rat and other species.
Robinson JW
J Physiol; 1970 Jan; 206(1):41-60. PubMed ID: 4250728
[TBL] [Abstract][Full Text] [Related]
15. Dissociation of contractile effect and binding and inhibition of Na+-K+-adenosine triphosphatase by cardiac glycosides in rabbit myometrium.
Murthy RV; Kidwai AM; Daniel EE
J Pharmacol Exp Ther; 1974 Mar; 188(3):575-81. PubMed ID: 4273912
[No Abstract] [Full Text] [Related]
16. Interactions of cardiac glycosides with cardiac cells. III. Alterations in the sensitivity of (Na+ +K+)-ATPase to inhibition by ouabain in rat hearts.
Schwalb H; Dickstein Y; Heller M
Biochim Biophys Acta; 1982 Jul; 689(2):241-8. PubMed ID: 6126212
[No Abstract] [Full Text] [Related]
17. Ouabain-receptor interactions in (Na+ plus K+)-ATPase preparations. IV. The molecular structure of different cardioactive steroids and other substances and their affinity to the glycoside receptor.
Erdmann E; Schoner W
Naunyn Schmiedebergs Arch Pharmacol; 1974; 283(4):335-56. PubMed ID: 4278432
[No Abstract] [Full Text] [Related]
18. Effect of age and cardiac glycosides on the activity of adenosine triphosphatase (ATPase) (EC 3.6.1.3) of red cell ghost membranes.
Platt D; Schoch P
Mech Ageing Dev; 1974; 3(5-6):245-52. PubMed ID: 4282388
[No Abstract] [Full Text] [Related]
19. The inhibition of the Na-K-ATPase of guinea-pig heart microsomes by cardiac glycosides.
Godfraind T; De Pover A
Arch Int Pharmacodyn Ther; 1973 Jan; 201(1):197-200. PubMed ID: 4268671
[No Abstract] [Full Text] [Related]
20. [Species differences in inhibition of (Na+ + K+)-activated ATPase by ouabain in the isolated membranes].
Eguchi N
Nihon Yakurigaku Zasshi; 1971 Jul; 67(4):362-73. PubMed ID: 4255840
[No Abstract] [Full Text] [Related]
[Next] [New Search]
